FEATURES OF THE DEVELOPMENT OF MORBIDITY AND MEDICAL CARE FOR PATIENTS WITH MALIGNANT NEOPLASMS OF THE RESPIRATORY SYSTEM

Authors

  • O.V. Feger
  • R.Y. Pohoriliak

DOI:

https://doi.org/10.32782/2077-6594.2.1.2022.258913

Keywords:

cancer incidence, malignant neoplasms of the respiratory system, providing medical care to cancer patients

Abstract

Objective. Study of the peculiarities of the development and course of the incidence of MNRS among the population of the Transcarpathian region, as well as the peculiarities of providing medical care to patients with this pathology.
Materials and methods. The object of the study – patients with MNRS living in the Transcarpathian region. This study was conducted using our questionnaire. Statistical analysis of the results was performed using Microsoft Excel.
Results. 196 questionnaires were received. It was found that 18.4% of patients came into contact with diesel evaporation, 53% of respondents smoked and only 12.2% quit smoking. It should be noted that the family of patients also suffered from chronic respiratory diseases and MNRS. It was found that only 30.6% of respondents applied for preventive assistance during the last year. 79.6% – suffered from respiratory diseases. First of all, 67.3% of patients sought help from a family outpatient clinic, 20.4% – to a polyclinic / hospital at the place of residence. Among the symptoms that most often bothered patients were: constant fatigue and lack of energy, loss of appetite and weight, fever, pain when breathing or coughing, shortness of breath, chest pain, continuous cough, loss, hoarseness, nasal congestion. At the time of the survey, 98.0% applied to a specialized medical institution, of which 73% applied for a doctor's referral and 20.4% on their own. 20.4% of respondents applied for diagnosis and 91.8% for treatment. 53.1% of patients do not know at what stage their disease was detected.
Conclusions. Thus, the identification of risk factors in patients with ASD will allow to form risk groups, and coordinated interaction of primary and specialized care will develop the patient's route, which will lead to timely detection of risk factors, their early diagnosis and treatment.

References

Зінчук А.М., Куцин М.В., Зінчук О.Г. Концептуальні напрямки оптимізації моделі раннього виявлення раку легень серед населення. Історичні, економічні, соціально-філософські та освітні аспекти розвитку охорони здоров'я: матеріали ІІІ Міжнародної науково-практичної інтернет-конференції. Харків, 2015: 79–82.

Профилактика рака и борьба с ним в контексте комплексного подхода. Семидесятая сессия всемирной ассамблеи здравоохранения WHA70.12. Шлях доступу: https://apps.who.int/iris/bitstream/handle/10665/275679/A70_R12-ru.pdf?sequence=1&isAllowed=y.

У 2019 році новоутворення стали другою найчастішою причиною смерті українців. Висновки з дослідження глобального тягаря хвороб. Шлях доступу: https://phc.org.ua/news/u-2019-roci-novoutvorennya-stali-drugoyu-naychastishoyu-prichinoyu-smerti-ukrainciv-visnovki-z.

Cancer deaths rose to 10 million worldwide in 2019. Шлях доступу: https://www.healthdata.org/news-release/cancer-deaths-rose-10-million-worldwide-2019.

Cancer. Шлях доступу: https://www.who.int/ru/news-room/fact-sheets/detail/cancer.

Cause-specific mortality, 2000–2019. Шлях доступу: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.

Global action plan for the prevention and control of NCDs 2013-2020. World Health Organization. Geneva. 2014: 114.

Global Burden of Disease 2019 Cancer Collaboration. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019. JAMA Oncology. 30 December 2021. doi: 10.1001/jamaoncol.2021.6987.

Hanna T.P., King W.D., Thibodeau S., Jalink M., Paulin G.A., Harvey-Jones E., O'Sullivan D.E., Booth C.M., Sullivan R., Aggarwal A.. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020 Nov 4; 371: m4087. doi:10.1136/bmj.m4087.

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021; 3 (71): 209-249. https://doi.org/10.3322/caac.21660.

Isabelle Soerjomataram, Aude Bardot, Joanne Aitken, Marion Piñeros, Ariana Znaor, Eva Steliarova-Foucher, Betsy Kohler, Manola Bettio, Tomohiro Matsuda, Marianna de Camargo Cancela, Les Mery, Freddie Bray. Impact of the COVID-19 pandemic on population-based cancer registry. International Journal of cancer. 2021. 2 (150): 273-278. https://doi.org/10.1002/ijc.33792.

Passaro A., Bestvina C., Velez Velez M., Garassino M.C., Garon E., Peters S.. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021 Mar; 9(3): e002266. doi: 10.1136/jitc-2020-002266.

Roundtable candid conversation hosted by WHO Cancer Ambassador Aron Anderson and launch of Cancer Screening Guide. Шлях доступу: https://www.euro.who.int/en/media-centre/events/events/2022/02/roundtable-candid-conversation-hosted-by-who-cancer-ambassador-aron-anderson-and-launch-of-cancer-screening-guide.

World Cancer Day. Шлях доступу: https://www.euro.who.int/en/media-centre/events/events/2022/02/world-cancer-day.

Published

2023-04-22